Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.8K citations

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Marc S. Greenblatt, W P Bennett, Monica Hollstein et al. · PubMed · 1994 · 3.5K citations

Tumor Biology, Cancer Pathology, Molecular Pathogenesis +9

Histological Grading and Prognosis in Breast Cancer

H. J. G. Bloom, W Richardson · British Journal of Cancer · 1957 · 2.9K citations · Full text

Breast Oncology, Medicine, Histopathology +6

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Gérard I. Evan, George K. Lewis, Gary Ramsay et al. · Molecular and Cellular Biology · 1985 · 2.4K citations

Immunocytochemical Technique, Immunology, Pathology +16

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

Kristina M. Dameron, Olga V. Volpert, Michael A. Tainsky et al. · Science · 1994 · 1.4K citations

Wild-type P53 Inhibits, Pathology, P53 Regulation +16